We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » VAXGEN RAISES $79M THROUGH SALE OF INTEREST IN OVERSEAS BIOPHARMACEUTICAL MANUFACTURING FACILITY
VAXGEN RAISES $79M THROUGH SALE OF INTEREST IN OVERSEAS BIOPHARMACEUTICAL MANUFACTURING FACILITY
June 29, 2006
VaxGen, Inc. announced today that it has realized gross proceeds of approximately
$79.0 million through the sale of a portion of its common shares in Celltrion,
Inc. VaxGen also granted the purchasers an exclusive option to acquire the remainder
of its Celltrion shares by December 31, 2006.
